This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Gyrus Medical Limited
Gyrus Medical Limited, a prominent player in the medical technology industry, is headquartered in Great Britain. Founded in the early 2000s, the company has established itself as a leader in the development of innovative surgical instruments and devices, particularly in the fields of endoscopy and minimally invasive surgery. With a strong presence in Europe and expanding operations globally, Gyrus Medical is renowned for its cutting-edge products, including advanced energy devices and endoscopic tools that enhance surgical precision and patient outcomes. The company’s commitment to quality and innovation has earned it a respected position in the market, marked by significant milestones in product development and strategic partnerships. Gyrus Medical continues to push the boundaries of medical technology, making a meaningful impact in healthcare.
DitchCarbon Score
How does Gyrus Medical Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Gyrus Medical Limited's score of 84 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Gyrus Medical Limited, headquartered in Great Britain, currently does not report specific carbon emissions data, as no figures are available. However, the company is part of a corporate family that includes Olympus Corporation, from which it inherits climate commitments and reduction targets. As a current subsidiary of Olympus Corporation, Gyrus Medical Limited aligns with the sustainability initiatives and targets set by its parent company. Olympus Corporation has established science-based targets (SBTi) and participates in the Carbon Disclosure Project (CDP), which guide its emissions reduction strategies. While specific reduction targets for Gyrus Medical Limited are not detailed, the overarching commitments from Olympus Corporation indicate a proactive approach to addressing climate change. This includes a focus on reducing emissions across all scopes, although specific figures for Scope 1, 2, or 3 emissions are not disclosed for Gyrus Medical Limited. In summary, while Gyrus Medical Limited does not provide its own emissions data, it is committed to the climate initiatives set forth by Olympus Corporation, reflecting a broader industry trend towards sustainability and carbon neutrality.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 31,972,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 91,418,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 3 | - | 00,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Gyrus Medical Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
